UroGen Pharma Ltd. Quarterly Current Ratio in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
UroGen Pharma Ltd. quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2024.
  • UroGen Pharma Ltd. Current Ratio for the quarter ending September 30, 2024 was 755 %, a 57.2% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 755 +274 +57.2% Sep 30, 2024
Q2 2024 703 +253 +56.1% Jun 30, 2024
Q1 2024 572 +7.65 +1.36% Mar 31, 2024
Q4 2023 485 -203 -29.5% Dec 31, 2023
Q3 2023 480 -203 -29.7% Sep 30, 2023
Q2 2023 451 -230 -33.8% Jun 30, 2023
Q1 2023 564 -109 -16.2% Mar 31, 2023
Q4 2022 688 +83.3 +13.8% Dec 31, 2022
Q3 2022 683 +69.3 +11.3% Sep 30, 2022
Q2 2022 680 +43.3 +6.8% Jun 30, 2022
Q1 2022 673 +27.2 +4.22% Mar 31, 2022
Q4 2021 605 -108 -15.2% Dec 31, 2021
Q3 2021 614 -169 -21.6% Sep 30, 2021
Q2 2021 637 -236 -27% Jun 30, 2021
Q1 2021 646 -397 -38.1% Mar 31, 2021
Q4 2020 713 -630 -46.9% Dec 31, 2020
Q3 2020 782 -630 -44.6% Sep 30, 2020
Q2 2020 873 -593 -40.5% Jun 30, 2020
Q1 2020 1.04K -390 -27.2% Mar 31, 2020
Q4 2019 1.34K +54 +4.19% Dec 31, 2019
Q3 2019 1.41K -63.6 -4.31% Sep 30, 2019
Q2 2019 1.47K Jun 30, 2019
Q1 2019 1.43K Mar 31, 2019
Q4 2018 1.29K Dec 31, 2018
Q3 2018 1.48K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.